Rainbow Childrens Medicare Q1 Results: Consolidated PAT rises 16% YoY to ₹625 million
Rainbow Children's Medicare Limited delivered robust Q1FY26 results with consolidated net profit rising 16.2% YoY to ₹625.40 million and revenue jumping 33.2% to ₹4,699.85 million. The growth was fueled by higher professional fees to doctors and expanded patient volumes. The Board also elevated Anshuman Jaiswal to Chief Legal Officer and announced strategic expansions in Mumbai and Nellore.
*this image is generated using AI for illustrative purposes only.
Rainbow Children's Medicare Limited reported a consolidated net profit after tax of ₹625.40 million for the quarter ended June 30, 2026, marking a 16.2% increase from ₹538.05 million in Q1FY25. Consolidated revenue from operations rose 33.2% year-on-year to ₹4,699.85 million, reflecting strong operational performance across its healthcare network. The growth was primarily driven by an increase in professional fees to doctors, which climbed to ₹1,238.19 million from ₹917.58 million in the corresponding period last year.
Standalone results showed a net profit after tax of ₹527.06 million, up 1.9% from ₹517.20 million in Q1FY25. Standalone revenue from operations increased 22.6% to ₹4,105.47 million. The company’s statutory auditors, S.R. Batliboi & Associates LLP, issued a limited review report on the unaudited standalone and consolidated financial results, confirming compliance with Ind AS 34 and SEBI Listing Regulations.
Financial Performance Highlights
The following table outlines the key financial metrics for the quarter ended June 30, 2026:
| Metric | Consolidated (₹ Million) | Standalone (₹ Million) | YoY Change (Consolidated) |
|---|---|---|---|
| Revenue from Operations | 4,699.85 | 4,105.47 | +33.2% |
| Total Income | 4,826.95 | 4,233.04 | +29.4% |
| Profit Before Tax | 839.53 | 705.41 | +17.6% |
| Net Profit After Tax | 625.40 | 527.06 | +16.2% |
| Earnings Per Share (Basic) | ₹5.97 | ₹5.20 | +13.3% |
Consolidated total income reached ₹4,826.95 million, including other income of ₹127.10 million. Total expenses amounted to ₹3,987.42 million, with employee benefits expense rising to ₹668.50 million and finance costs increasing to ₹212.05 million. The effective tax rate remained stable, with total tax expense at ₹214.13 million.
Strategic Developments and Governance
In addition to financial results, the Board of Directors approved the elevation of Anshuman Jaiswal from Group Head – Legal to Chief Legal Officer. Effective July 30, 2026, he has been designated as Senior Management Personnel (SMP) in accordance with SEBI Listing Regulations. Jaiswal brings over two decades of experience, including tenures at Amarchand Mangaldas and Greenko Group.
Subsequent to the quarter end, the company executed definitive transaction documents for a new children and women’s hospital at Malad, Mumbai, through its subsidiary Rainbow Women & Children’s Hospital Private Limited. The transaction is expected to complete in the quarter ended September 30, 2026. Additionally, Rainbow Children's Medicare signed a Partnership Interest and Contribution Transfer Agreement to acquire a 64% stake in Super Prime Medical Care LLP for ₹198 million, targeting a running children’s hospital in Nellore, Andhra Pradesh.
What the Numbers Show
The divergence between standalone and consolidated revenue growth highlights the impact of recent acquisitions and subsidiaries on top-line performance. While standalone revenue grew 22.6%, consolidated revenue surged 33.2%, indicating that newer entities or consolidating entities contributed disproportionately to growth. Professional fees to doctors, the largest expense line item, grew faster than revenue, suggesting a shift towards higher-complexity care or increased specialist engagement. Despite this cost pressure, net profit margins improved slightly, demonstrating operational leverage in other areas such as material costs and administrative expenses.
Historical Stock Returns for Rainbow Childrens Medicare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.32% | +4.04% | +7.86% | +34.03% | +0.54% | +238.83% |
How will the upcoming acquisition of the 64% stake in Super Prime Medical Care LLP impact Rainbow Children's Medicare's consolidated revenue and EBITDA margins in FY27?
What is the projected timeline for the new Malad, Mumbai hospital to reach operational breakeven, and how does this expansion align with the company's capital allocation strategy?
Given that professional fees to doctors grew faster than revenue, what measures is management taking to control this cost driver while maintaining specialist engagement levels?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
